chloro-3-tert-pentylbenzene | 857579-16-9

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: chloro-3-tert-pentylbenzene
• 英文别名: 1-Chloro-3-(2-methylbutan-2-yl)benzene
• CAS: 857579-16-9
• 化学式: C₁₁H₁₅Cl
• 分子量: 182.693
• InChiKey: NERLWPWKSIGBOV-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  5.1
• 重原子数：
  12
• 可旋转键数：
  2
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.45
• 拓扑面积：
  0
• 氢给体数：
  0
• 氢受体数：
  0

反应信息

• 作为产物：
  描述：

  2-(3-chlorophenyl)-2-butanol 在 氯化亚砜 作用下， 以 正己烷 、 二氯甲烷 为溶剂， 反应 2.0h， 生成 chloro-3-tert-pentylbenzene
  参考文献：
  名称：

  Access to “Friedel–Crafts-Restricted” tert-Alkyl Aromatics by Activation/Methylation of Tertiary Benzylic Alcohols

  摘要：

  Herein we describe a two-step protocol to prepare m-tert-alkylbenzenes. The appropriate tertiary benzylic alcohols are activated with SOCl2 or concentrated HCl and then treated with trimethylaluminum, affording the desired products in 68-97% yields (22 examples). This reaction sequence is successful in the presence of a variety of functional groups, including acid-sensitive and Lewis-basic groups. In addition to t-Bu groups, 1,1-dimethylpropyl and 1-ethyl-1-methylpropyl groups can also be installed using this method.

  DOI：

  10.1021/jo202371c

文献信息

• Heterocyclic compound, composition including the same, and organic light-emitting device including the heterocyclic compound
  申请人：Samsung Electronics Co., Ltd.

  公开号：US20200207739A1

  公开（公告）日：2020-07-02

  A heterocyclic compound represented by Formula 1, a composition including the same, and an organic light-emitting device including the heterocyclic compound: L 1 to L 4 , L 11 , a1 to a4, a11, Ar 1 , Ar 2 , Ar 11 , R 1 to R 7 , R 11 to R 12 , b1 to b7, and b11 to b12 are described in the specification.

  由公式1表示的杂环化合物，包括该化合物的组合物，以及包括该杂环化合物的有机发光器件：规范中描述了L1至L4，L11，a1至a4，a11，Ar1，Ar2，Ar11，R1至R7，R11至R12，b1至b7以及b11至b12。
• Charged ion channel blockers and methods for use
  申请人：Nocion Therapeutics, Inc.

  公开号：US10842798B1

  公开（公告）日：2020-11-24

  The invention provides compounds of Formula (I), or pharmaceutically acceptable salts thereof: The compounds, compositions, methods and kits of the invention are useful for the treatment of pain, itch, and neurogenic inflammation.

  该发明提供了公式(I)的化合物或其药学上可接受的盐：该发明的化合物、组合物、方法和试剂盒对于治疗疼痛、瘙痒和神经源性炎症是有用的。
• Diaryl, Dipyridinyl and Aryl-Pyridinyl Derivatives and Uses Thereof
  申请人：Ruggeri Roger B.

  公开号：US20080167371A1

  公开（公告）日：2008-07-10

  Compounds of Formula (I) that act as antagonists at the mu, kappa and/or delta opioid receptors and therefore useful in the treatment of diseases, conditions and/or disorders that benefit from such antagonism in animals are described herein. where R, R 1 , R 2a , R 2b , R 3 , R 4 , V, R 6 , R 7 , R 8 , R 9 , W and X are described herein.

  本文描述了化学式（I）的化合物，它们作为mu、kappa和/或delta阿片受体拮抗剂，因此对于需要这种拮抗作用的动物的疾病、状况和/或障碍的治疗是有用的。其中R、R1、R2a、R2b、R3、R4、V、R6、R7、R8、R9、W和X的描述在此处给出。
• HDAC8 inhibitors for treating cancer
  申请人：City of Hope

  公开号：US10308596B2

  公开（公告）日：2019-06-04

  Provided herein, inter alia, are compound and methods of treating cancer by inhibiting HDAC8.

  本文特别提供了通过抑制 HDAC8 治疗癌症的化合物和方法。
• Aryl dihydro-2H-benzo[b][1,4]oxazine sulfonamide and related compounds for use as agonists of RORγ and the treatment of disease
  申请人：Lycera Corporation

  公开号：US10611740B2

  公开（公告）日：2020-04-07

  The invention provides aryl dihydro-2H-benzo[b] [1,4]oxazine sulfonamide and related compounds, pharmaceutical compositions, methods of promoting RORy activity, methods of increasing the amount of IL-17 in a subject, and methods of treating cancer and other medical disorders using such compounds.

  本发明提供了芳基二氢-2H-苯并[b][1,4]恶嗪磺酰胺及相关化合物、药物组合物、促进 RORy 活性的方法、增加受试者体内 IL-17 数量的方法以及使用此类化合物治疗癌症和其他疾病的方法。